Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.17 USD | -3.76% | -6.34% | -40.85% |
09/05 | Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System | CI |
07/05 | Transcript : Pulse Biosciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-40.85% | 411M | |
+11.20% | 226B | |
+8.96% | 188B | |
+13.21% | 137B | |
+26.07% | 108B | |
+0.34% | 63.19B | |
+11.36% | 52.26B | |
+5.62% | 51B | |
+6.28% | 43.89B | |
+4.77% | 38.07B |
- Stock Market
- Equities
- PLSE Stock
- News Pulse Biosciences, Inc.
- Pulse Biosciences Files FDA Notification to Advance Testing of New Cardiac Clamp